Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate.

MLA

Takeuchi, Tsutomu, et al. “Phase II Dose-Response Study of Abatacept in Japanese Patients with Active Rheumatoid Arthritis with an Inadequate Response to Methotrexate.” Modern Rheumatology, vol. 23, no. 2, Mar. 2013, pp. 226–35. EBSCOhost, https://doi.org/10.1007/s10165-012-0668-z.

APA

Takeuchi, T., Matsubara, T., Nitobe, T., Suematsu, E., Ohta, S., Honjo, S., Abe, T., Yamamoto, A., & Miyasaka, N. (2013). Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate. Modern Rheumatology, 23(2), 226–235. https://doi.org/10.1007/s10165-012-0668-z

Chicago

Takeuchi, Tsutomu, Tsukasa Matsubara, Taisuke Nitobe, Eiichi Suematsu, Syuji Ohta, Shigeru Honjo, Tohru Abe, Ami Yamamoto, and Nobuyuki Miyasaka. 2013. “Phase II Dose-Response Study of Abatacept in Japanese Patients with Active Rheumatoid Arthritis with an Inadequate Response to Methotrexate.” Modern Rheumatology 23 (2): 226–35. doi:10.1007/s10165-012-0668-z.